Hindman Andrew A.

SVP, CHIEF FINANCIAL OFFICER at TBPH; Chief Business Officer at ACORDA THERAPEUTICS INC

Sold, on record
$2.2M
Dollars the filings state
Form 4 sales
9
Latest Nov 18, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ACORDA THERAPEUTICS INCPlan not stated
    Dec 1, 2015 2015

    Sold 442 shares at $38.26 ($17k)

    Hindman Andrew A., Chief Business Dev. Officer

    Sold 0.8% of holdings ($2.1M position)54,530 shares leftFiling

  2. 2 Form 4 sale ACORDA THERAPEUTICS INCPlan not stated
    May 13, 2016 +164 days

    Sold 4,860 shares at $26.11 ($127k)

    Hindman Andrew A., Chief Business Dev. Officer

    Sold 8.9% of holdings ($1.4M position)49,670 shares leftFiling

  3. 3 Form 4 sale ACORDA THERAPEUTICS INCPlan not stated
    Dec 1, 2016 +202 days

    Sold 443 shares at $20.72 ($9k)

    Hindman Andrew A., Chief Business Dev. Officer

    Sold 0.9% of holdings ($1M position)49,227 shares left0.1x usual sizeFiling

  4. 4 Form 4 sale ACORDA THERAPEUTICS INCUnusual
    May 15, 2017 +165 days

    Sold 7,704 shares at $15.75 ($121k)

    Hindman Andrew A., Chief Business Dev. Officer

    Sold 14.3% of holdings ($848k position)46,123 shares left17.4x usual sizeFiling

  5. 5 Form 4 sale ACORDA THERAPEUTICS INCPlan not stated
    Dec 1, 2017 +200 days

    Sold 817 shares at $20.54 ($17k)

    Hindman Andrew A., Chief Business Dev. Officer

    Sold 1.8% of holdings ($947k position)45,306 shares left0.2x usual sizeFiling

  6. 6 Form 4 sale ACORDA THERAPEUTICS INCUnusual
    May 25, 2018 +175 days

    Sold 42,615 shares at $24.26 ($1M)

    Hindman Andrew A., Chief Business Officer

    Sold 90.4% of holdings ($1.1M position)4,503 shares left52.2x usual sizeFiling

  7. 7 Form 4 sale ACORDA THERAPEUTICS INCPlan not stated
    Dec 3, 2018 +192 days

    Sold 753 shares at $20.56 ($15k)

    Hindman Andrew A., Chief Business Officer

    Sold 12.7% of holdings ($122k position)5,171 shares left0.1x usual sizeFiling

  8. 8 Form 4 sale TBPHPlan not stated
    Nov 18, 2022 +1446 days

    Sold 65,000 shares at $11.02 ($716k)

    Hindman Andrew A., SVP, CHIEF FINANCIAL OFFICER

    Sold 13.7% of holdings ($5.2M position)409,771 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Hindman Andrew A.
Source
Nov 18, 2022Nov 22, 2022TBPHSVP, CHIEF FINANCIAL OFFICERForm 4 sale65,000$716k13.7%Plan not statedSEC
Dec 3, 2018Dec 6, 2018ACORDA THERAPEUTICS INCChief Business OfficerForm 4 sale753$15k12.7%Plan not statedSEC
May 25, 2018May 30, 2018ACORDA THERAPEUTICS INCChief Business OfficerForm 4 sale42,615$1M90.4%UnusualSEC
Dec 1, 2017Dec 5, 2017ACORDA THERAPEUTICS INCChief Business Dev. OfficerForm 4 sale817$17k1.8%Plan not statedSEC
May 15, 2017May 17, 2017ACORDA THERAPEUTICS INCChief Business Dev. OfficerForm 4 sale7,704$121k14.3%UnusualSEC
Dec 1, 2016Dec 5, 2016ACORDA THERAPEUTICS INCChief Business Dev. OfficerForm 4 sale443$9k0.9%Plan not statedSEC
May 13, 2016May 16, 2016ACORDA THERAPEUTICS INCChief Business Dev. OfficerForm 4 sale4,860$127k8.9%Plan not statedSEC
Dec 1, 2015Dec 3, 2015ACORDA THERAPEUTICS INCChief Business Dev. OfficerForm 4 sale442$17k0.8%Plan not statedSEC
May 15, 2015May 15, 2015ACORDA THERAPEUTICS INCChief Business Dev. OfficerForm 4 sale4,779$142k8.0%Plan not statedSEC